Evidence map›Paper›PMID 36814262›Full record

ArticleBMC medical informatics and decision making2023

Public attitudes towards the use of novel technologies in their future healthcare: a UK survey.

Sarah Sauchelli, Tim Pickles, Alexandra Voinescu, Heungjae Choi, Ben Sherlock, Jingjing Zhang, Steffi Colyer, Sabrina Grant, Sethu Sundari, Gemma Lasseter

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Exergaming for dementia and mild cognitive impairment.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah SauchelliNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals of Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK. sarah.sauchellitoran@bristol.ac.uk.
Tim PicklesCentre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
Alexandra VoinescuDepartment of Psychology, University of Bath, Bath, UK.
Heungjae ChoiSchool of Engineering, Cardiff University, Cardiff, UK.
Ben SherlockCollege of Medicine and Health, University of Exeter, Exeter, UK.
Jingjing ZhangDepartment of Mathematical Sciences, University of Essex, Colchester, UK.
Steffi ColyerDepartment of Health, University of Bath, Bath, UK.
Sabrina GrantMusculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Sethu SundariSchool of Nursing and Midwifery, University of Worcester, Worcester, UK.
Gemma LasseterNIHR Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, University of Bristol in Collaboration with UK Health Security Agency (UKHSA), Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.

Funding

Engineering and Physical Sciences Research Council EP/P00945X/1European Regional Development Fund (Wales) TG/KJB/VSM:1103515HCRW_ NIHR-FS-19
6 · The paper itself

Abstract

backgroundInnovation in healthcare technologies can result in more convenient and effective treatment that is less costly, but a persistent challenge to widespread adoption in health and social care is end user acceptability. The purpose of this study was to capture UK public opinions and attitudes to novel healthcare technologies (NHTs), and to better understand the factors that contribute to acceptance and future use.

methodsAn online survey was distributed to the UK public between April and May 2020. Respondents received brief information about four novel healthcare technologies (NHTs) in development: a laser-based tool for early diagnosis of osteoarthritis, a virtual reality tool to support diabetes self-management, a non-invasive continuous glucose monitor using microwave signals, a mobile app for patient reported monitoring of rheumatoid arthritis. They were queried on their general familiarity and attitudes to technology, and their willingness to accept each NHT in their future care. Responses were analysed using summary statistics and content analysis.

resultsKnowledge about NHTs was diverse, with respondents being more aware about the health applications of mobile apps (66%), followed by laser-based technology (63.8%), microwave signalling (28%), and virtual reality (18.3%). Increasing age and the presence of a self-reported medical condition favoured acceptability for some NHTs, whereas self-reported understanding of how the NHT works resulted in elevated acceptance scores across all NHTs presented. Common contributors to hesitancy were safety and risks from use. Respondents wanted more information and evidence to help inform their decisions, ideally provided verbally by a general practitioner or health professional. Other concerns, such as privacy, were NHT-specific but equally important in decision-making.

conclusionsEarly insight into the knowledge and preconceptions of the public about NHTs in development can assist their design and prospectively mitigate obstacles to acceptance and adoption.

Indexed as

Delivery of Health CareMobile ApplicationsAttitudeHumansSurveys and QuestionnairesUnited KingdomAcceptabilityAttitudesLaserMicrowave signalsMobile applicationNovel healthcare technologiesSurveyVirtual reality

Identifiers

PMID36814262
PMCPMC9944774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.